Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Selectin E/CD62e antibody (FITC)

This Mouse Monoclonal antibody specifically detects Selectin E/CD62e in FACS. It exhibits reactivity toward Human.
Catalog No. ABIN206434

Quick Overview for Selectin E/CD62e antibody (FITC) (ABIN206434)

Target

See all Selectin E/CD62e (SELE) Antibodies
Selectin E/CD62e (SELE) (Selectin E (SELE))

Reactivity

  • 82
  • 34
  • 24
  • 13
  • 8
  • 6
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 73
  • 47
  • 13
  • 4
  • 1
Mouse

Clonality

  • 80
  • 58
Monoclonal

Conjugate

  • 89
  • 15
  • 12
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This Selectin E/CD62e antibody is conjugated to FITC

Application

  • 85
  • 61
  • 53
  • 42
  • 39
  • 30
  • 19
  • 14
  • 10
  • 7
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Purification

    Purified

    Isotype

    IgG2a
  • Application Notes

    Approved: Flo

    Usage: Flow Cytometry: Use 10 μL of the suggested working dilution to label 10^6 cells in 100 μL. Method sheets are available on request. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Tris-sodium chloride, 0.02 % sodium azide, 1 % BSA.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    Selectin E/CD62e (SELE) (Selectin E (SELE))

    Alternative Name

    SELE / CD62E / E-Selectin

    Background

    Name/Gene ID: SELE

    Synonyms: SELE, CD62E, ELAM, ESEL, E-selectin, LECAM2, CD62E antigen, ELAM-1, ELAM1, Selectin E

    Gene ID

    6401

    Pathways

    Thromboxane A2 Receptor Signaling
You are here:
Chat with us!